Tuesday, July 23, 2019
    Latest

    Kidney

    Home Kidney
    New Drug reduces risks of Type 2 Diabetes
    Kidney

    Large International REWIND Trial Finds Dulaglutide Reduces Cardiovascular & Kidney Problems...

    0
    Kidney

    Janssen’s Diabetes Drug Canagliflozin Lowers Kidney Failure Risk According to Trial

    0
    Kidney Cancer
    Kidney

    TrialWatch: JAVELIN Renal 101 Trial Reveals Progress for Treating Advanced Kidney...

    0
    Kidney

    NCCS & Lucence Predict Immunotherapy Response for Kidney Cancer

    0
    Kidney

    TrialWatch: CheckMate-214 Trial Shows Promising Results with Opdivo & Yervoy For...

    0
    Kidney

    PriceWatch: NHS Turns Down BMS Immunotherapy Combo for Advanced Kidney Cancer

    0
    Kidney

    Trial Watch: Aveo Oncology’s Tivozanib Reveals Positive Results for Advanced Renal...

    0
    Kidney

    FNIH & C-Path Achieve First Ever Qualification of Clinical Safety Biomarker...

    0
    Kidney

    International Study: Nephrotic Syndrome Risks for Children

    0
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved